The American Recovery and Reinvestment Act of 2009 provided billions of dollars in new health and health care spending. The Act appropriates funding to support and coordinate comparative effectiveness research, which compares treatment and strategies for improving health outcomes. This brief examines the Act's comparative effectiveness provisions.
Access full PDF article by clicking here. [Updated April 18, 2016]
Enter the password to open this PDF file:
.png)